Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126627) titled 'Mechanistic Study of IL-25 in Ameliorating Metabolic Associated Fatty Liver Disease via the Gut-Liver Axis' on June 12.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Shenzhen Hospital of Southern Medical Unversity
Condition:
metabolic dysfunction-associated fatty liver disease
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-27
Target Sample Size: Observation group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=282644
Published by HT Digital Content Services with permission from Health...